Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001140361-25-009017

President sold 4,000 shares at an average $12.06 ($48,220)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ma Songjiang · President

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-13 Sale : show line 1 in the form 10b5-1 −2,000 $11.80 $23,600 2,833,260 I
2025-03-14 Sale : show line 2 in the form 10b5-1 −2,000 $12.31 $24,620 2,831,260 I
Open-market sales · 4,000 sh · avg $12.06 · $48,220
Loading xslF345X05/form4.xml…